In conclusion, by introducing a novel intragenic variant (de novo deletion von exons 15 to 16) leading to haploinsufficiency and associated with the clinical manifestation of PTHS, we expand the current molecular genetic landscape of TCF4 (NM_003199.2). This evidence concerns the gene TCF4 and Pitt-Hopkins syndrome.